For example, in NAFLD, myocellular autophagy is enhanced as a metabolic response to hyperammonemia [205], or in animals with hypertension, autophagy markers, including LC3I, ATG7, and lysosome-associated membrane protein 2 (LAMP2), are increased in skeletal muscle [206]. This evidence concerns the gene ATG7 and metabolic dysfunction-associated steatotic liver disease.